Outcome-specific shifts in homocysteine-androgen correlations in polycystic ovary syndrome - Report - MDSpire

Outcome-specific shifts in homocysteine-androgen correlations in polycystic ovary syndrome

  • By

  • Qian Han

  • Jiarun Zhao

  • Mengyuan Li

  • Mingwei Xin

  • Xiaodan Yin

  • Junqin He

  • April 7, 2026

  • 0 min

Share

Outcome-Dependent Variations in Homocysteine-Androgen Relationships in PCOS Women

Overview

This study reveals that the associations between homocysteine (HCY) and androgen levels in women with polycystic ovary syndrome (PCOS) vary significantly depending on reproductive outcomes. Infertile PCOS patients show broad positive correlations between HCY and multiple androgens, while pregnant women exhibit narrower and outcome-specific patterns, including a positive association with total testosterone in live births and a negative association with DHEA in spontaneous abortions.

Background

Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder characterized by hyperandrogenism, insulin resistance, and ovulatory dysfunction, leading to infertility and increased risk of pregnancy complications. Elevated homocysteine (HCY) levels are common in PCOS and may contribute to hyperandrogenism and adverse reproductive outcomes. However, the relationship between HCY and androgen profiles across different reproductive outcomes in PCOS remains unclear. Understanding these associations could improve risk stratification and management of reproductive dysfunction in PCOS.

Data Highlights

GroupSample Size (n)HCY-Androgen Correlation Pattern
Infertility302Broad positive correlations with TT, Bio-T, FT, FAI (β=0.12–0.21, P<0.01)
Pregnancy573Narrower correlations overall
Live Birth266Positive association between HCY and TT (β=0.30, P<0.01)
Spontaneous Abortion292Negative association between HCY and DHEA (β=-0.16, P=0.02)

Key Findings

  • Metabolic disturbances were most severe in infertile PCOS patients, intermediate in spontaneous abortion cases, and least pronounced in live birth cases (all P < 0.05).
  • In infertile patients, HCY positively correlated with multiple androgen measures including total testosterone, bioavailable testosterone, free testosterone, and free androgen index.
  • Pregnant PCOS women showed reduced breadth of HCY-androgen correlations compared to infertile patients.
  • Within pregnancy subgroups, HCY was positively associated with total testosterone in women who achieved live birth.
  • Conversely, HCY was negatively associated with dehydroepiandrosterone (DHEA) in women who experienced spontaneous abortion.

Clinical Implications

These findings suggest that the relationship between homocysteine and androgen levels in PCOS is influenced by reproductive outcomes, highlighting the importance of tailored metabolic and hormonal assessment in this population. Monitoring HCY and androgen profiles may aid in identifying women at higher risk for infertility or adverse pregnancy outcomes, potentially guiding personalized interventions to improve reproductive success.

Conclusion

The study demonstrates that homocysteine-androgen associations in PCOS women are dependent on reproductive outcomes, with distinct patterns observed in infertility, live birth, and spontaneous abortion groups. These insights may enhance understanding of PCOS heterogeneity and inform clinical risk stratification across reproductive stages.

References

  1. Study Authors/Beijing Obstetrics and Gynecology Hospital/2026 -- Outcome-dependent variations in the relationship between homocysteine and androgen levels in women with polycystic ovary syndrome

Original Source(s)

Related Content